Solvi Rognvaldsson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Solvi Rognvaldsson has a total of 176 co-authors. Here are the top co-authors by number of shared publications:
Lilja Stefansdottir
DeCODE genetics/AMGEN Inc., Reykjavik, Iceland
8 shared publicationsUnnur Thorsteinsdottir
DeCODE genetics/AMGEN Inc., Reykjavik, Iceland
8 shared publications- Bjarni V. Halldorsson
DeCODE genetics/Amgen, Reykjavik, Iceland
7 shared publications - Kari Stefansson
DeCODE genetics/AMGEN Inc., Reykjavik, Iceland
7 shared publications Pall Melsted
DeCODE genetics/AMGEN Inc., Reykjavik, Iceland
7 shared publicationsRun Fridriksdottir
DeCODE genetics/AMGEN Inc., Reykjavik, Iceland
7 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by Institute of Mathematical Statistics in Statistical Science
- Vol. 40 (1) , 128-147
Advances in Projection Predictive Inference
The concepts of Bayesian prediction, model comparison, and model selection have developed significantly over the last decade. As a result, the Bayesian community has witnessed a rapid growth in theoretical and applied contributions to building and selecting predictive models. Projection predictive inference in particular has shown promise to this end, finding application across a broad range of fields. It is less prone to over-fitting than naïve selection based purely on cross-validation or information criteria performance metrics, and has been known to out-perform other methods in terms of predictive performance. We survey the core concept and contemporary contributions to projection predictive inference, and present a safe, efficient, and modular workflow for prediction-oriented model selection therein. We also provide an interpretation of the projected posteriors achieved by projection predictive inference in terms of their limitations in causal settings.
- 1 January 2025
- Published by Institute of Mathematical Statistics in Statistical Science
- Vol. 40 (1) , 128-147
Open AccessAdvances in Projection Predictive Inference
The concepts of Bayesian prediction, model comparison, and model selection have developed significantly over the last decade. As a result, the Bayesian community has witnessed a rapid growth in theoretical and applied contributions to building and selecting predictive models. Projection predictive inference in particular has shown promise to this end, finding application across a broad range of fields. It is less prone to over-fitting than naïve selection based purely on cross-validation or information criteria performance metrics, and has been known to out-perform other methods in terms of predictive performance. We survey the core concept and contemporary contributions to projection predictive inference, and present a safe, efficient, and modular workflow for prediction-oriented model selection therein. We also provide an interpretation of the projected posteriors achieved by projection predictive inference in terms of their limitations in causal settings.
- Open Access
- 20 December 2024
- Published by Elsevier in Journal of Hydrology
- Vol. 651
Evaluating the applicability of the generalized power-law rating curve model
- 20 December 2024
- Published by Elsevier in Journal of Hydrology
- Vol. 651
Open AccessEvaluating the applicability of the generalized power-law rating curve model
- Open Access
- 10 July 2023
- Published by Springer Nature in Communications Biology
- Vol. 6 (1) , 1-9
Sequence variant affects GCSAML splicing, mast cell specific proteins, and risk of urticaria
Urticaria is a skin disorder characterized by outbreaks of raised pruritic wheals. In order to identify sequence variants associated with urticaria, we performed a meta-analysis of genome-wide association studies for urticaria with a total of 40,694 cases and 1,230,001 controls from Iceland, the UK, Finland, and Japan. We also performed transcriptome- and proteome-wide analyses in Iceland and the UK. We found nine sequence variants at nine loci associating with urticaria. The variants are at genes participating in type 2 immune responses and/or mast cell biology (CBLB, FCER1A, GCSAML, STAT6, TPSD1, ZFPM1), the innate immunity (C4), and NF-κB signaling. The most significant association was observed for the splice-donor variant rs56043070[A] (hg38: chr1:247556467) in GCSAML (MAF = 6.6%, OR = 1.24 (95%CI: 1.20–1.28), P-value = 3.6 × 10-44). We assessed the effects of the variants on transcripts, and levels of proteins relevant to urticaria pathophysiology. Our results emphasize the role of type 2 immune response and mast cell activation in the pathogenesis of urticaria. Our findings may point to an IgE-independent urticaria pathway that could help address unmet clinical need.
- 10 July 2023
- Published by Springer Nature in Communications Biology
- Vol. 6 (1) , 1-9
Open AccessSequence variant affects GCSAML splicing, mast cell specific proteins, and risk of urticaria
Urticaria is a skin disorder characterized by outbreaks of raised pruritic wheals. In order to identify sequence variants associated with urticaria, we performed a meta-analysis of genome-wide association studies for urticaria with a total of 40,694 cases and 1,230,001 controls from Iceland, the UK, Finland, and Japan. We also performed transcriptome- and proteome-wide analyses in Iceland and the UK. We found nine sequence variants at nine loci associating with urticaria. The variants are at genes participating in type 2 immune responses and/or mast cell biology (CBLB, FCER1A, GCSAML, STAT6, TPSD1, ZFPM1), the innate immunity (C4), and NF-κB signaling. The most significant association was observed for the splice-donor variant rs56043070[A] (hg38: chr1:247556467) in GCSAML (MAF = 6.6%, OR = 1.24 (95%CI: 1.20–1.28), P-value = 3.6 × 10-44). We assessed the effects of the variants on transcripts, and levels of proteins relevant to urticaria pathophysiology. Our results emphasize the role of type 2 immune response and mast cell activation in the pathogenesis of urticaria. Our findings may point to an IgE-independent urticaria pathway that could help address unmet clinical need.
- Open Access
- 9 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (23) , eabq2969
Sequence variants affecting voice pitch in humans
The genetic basis of the human vocal system is largely unknown, as are the sequence variants that give rise to individual differences in voice and speech. Here, we couple data on diversity in the sequence of the genome with voice and vowel acoustics in speech recordings from 12,901 Icelanders. We show how voice pitch and vowel acoustics vary across the life span and correlate with anthropometric, physiological, and cognitive traits. We found that voice pitch and vowel acoustics have a heritable component and discovered correlated common variants in ABCC9 that associate with voice pitch. The ABCC9 variants also associate with adrenal gene expression and cardiovascular traits. By showing that voice and vowel acoustics are influenced by genetics, we have taken important steps toward understanding the genetics and evolution of the human vocal system.
- 9 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (23) , eabq2969
Open AccessSequence variants affecting voice pitch in humans
The genetic basis of the human vocal system is largely unknown, as are the sequence variants that give rise to individual differences in voice and speech. Here, we couple data on diversity in the sequence of the genome with voice and vowel acoustics in speech recordings from 12,901 Icelanders. We show how voice pitch and vowel acoustics vary across the life span and correlate with anthropometric, physiological, and cognitive traits. We found that voice pitch and vowel acoustics have a heritable component and discovered correlated common variants in ABCC9 that associate with voice pitch. The ABCC9 variants also associate with adrenal gene expression and cardiovascular traits. By showing that voice and vowel acoustics are influenced by genetics, we have taken important steps toward understanding the genetics and evolution of the human vocal system.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Material from Loss-of-Function Variants in the Tumor-Suppressor Gene PTPN14 Confer Increased Cancer Risk
Supplementary Methods, Supplementary Tables 1-18 and Supplementary Figures 1-5.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Material from Loss-of-Function Variants in the Tumor-Suppressor Gene PTPN14 Confer Increased Cancer Risk
Supplementary Methods, Supplementary Tables 1-18 and Supplementary Figures 1-5.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Material from Loss-of-Function Variants in the Tumor-Suppressor Gene PTPN14 Confer Increased Cancer Risk
Supplementary Methods, Supplementary Tables 1-18 and Supplementary Figures 1-5.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Material from Loss-of-Function Variants in the Tumor-Suppressor Gene PTPN14 Confer Increased Cancer Risk
Supplementary Methods, Supplementary Tables 1-18 and Supplementary Figures 1-5.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Loss-of-Function Variants in the Tumor-Suppressor Gene PTPN14 Confer Increased Cancer Risk
The success of genome-wide association studies (GWAS) in identifying common, low-penetrance variant-cancer associations for the past decade is undisputed. However, discovering additional high-penetrance cancer mutations in unknown cancer predisposing genes requires detection of variant-cancer association of ultra-rare coding variants. Consequently, large-scale next-generation sequence data with associated phenotype information are needed. Here, we used genotype data on 166,281 Icelanders, of which, 49,708 were whole-genome sequenced and 408,595 individuals from the UK Biobank, of which, 41,147 were whole-exome sequenced, to test for association between loss-of-function burden in autosomal genes and basal cell carcinoma (BCC), the most common cancer in Caucasians. A total of 25,205 BCC cases and 683,058 controls were tested. Rare germline loss-of-function variants in PTPN14 conferred substantial risks of BCC (OR, 8.0; P = 1.9 × 10−12), with a quarter of carriers getting BCC before age 70 and over half in their lifetime. Furthermore, common variants at the PTPN14 locus were associated with BCC, suggesting PTPN14 as a new, high-impact BCC predisposition gene. A follow-up investigation of 24 cancers and three benign tumor types showed that PTPN14 loss-of-function variants are associated with high risk of cervical cancer (OR, 12.7, P = 1.6 × 10−4) and low age at diagnosis. Our findings, using power-increasing methods with high-quality rare variant genotypes, highlight future prospects for new discoveries on carcinogenesis.Significance:This study identifies the tumor-suppressor gene PTPN14 as a high-impact BCC predisposition gene and indicates that inactivation of PTPN14 by germline sequence variants may also lead to increased risk of cervical cancer.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Loss-of-Function Variants in the Tumor-Suppressor Gene PTPN14 Confer Increased Cancer Risk
The success of genome-wide association studies (GWAS) in identifying common, low-penetrance variant-cancer associations for the past decade is undisputed. However, discovering additional high-penetrance cancer mutations in unknown cancer predisposing genes requires detection of variant-cancer association of ultra-rare coding variants. Consequently, large-scale next-generation sequence data with associated phenotype information are needed. Here, we used genotype data on 166,281 Icelanders, of which, 49,708 were whole-genome sequenced and 408,595 individuals from the UK Biobank, of which, 41,147 were whole-exome sequenced, to test for association between loss-of-function burden in autosomal genes and basal cell carcinoma (BCC), the most common cancer in Caucasians. A total of 25,205 BCC cases and 683,058 controls were tested. Rare germline loss-of-function variants in PTPN14 conferred substantial risks of BCC (OR, 8.0; P = 1.9 × 10−12), with a quarter of carriers getting BCC before age 70 and over half in their lifetime. Furthermore, common variants at the PTPN14 locus were associated with BCC, suggesting PTPN14 as a new, high-impact BCC predisposition gene. A follow-up investigation of 24 cancers and three benign tumor types showed that PTPN14 loss-of-function variants are associated with high risk of cervical cancer (OR, 12.7, P = 1.6 × 10−4) and low age at diagnosis. Our findings, using power-increasing methods with high-quality rare variant genotypes, highlight future prospects for new discoveries on carcinogenesis.Significance:This study identifies the tumor-suppressor gene PTPN14 as a high-impact BCC predisposition gene and indicates that inactivation of PTPN14 by germline sequence variants may also lead to increased risk of cervical cancer.
- 5 December 2021
- Published by Wiley in Environmetrics
- Vol. 33 (2)
Generalization of the power‐law rating curve using hydrodynamic theory and Bayesian hierarchical modeling
- 5 December 2021
- Published by Wiley in Environmetrics
- Vol. 33 (2)
Generalization of the power‐law rating curve using hydrodynamic theory and Bayesian hierarchical modeling
- Top Cited Papers
- 2 December 2021
- Published by Springer Nature in Nature Genetics
- Vol. 53 (12) , 1712-1721
Large-scale integration of the plasma proteome with genetics and disease
The plasma proteome can help bridge the gap between the genome and diseases. Here we describe genome-wide association studies (GWASs) of plasma protein levels measured with 4,907 aptamers in 35,559 Icelanders. We found 18,084 associations between sequence variants and levels of proteins in plasma (protein quantitative trait loci; pQTL), of which 19% were with rare variants (minor allele frequency (MAF) < 1%). We tested plasma protein levels for association with 373 diseases and other traits and identified 257,490 associations. We integrated pQTL and genetic associations with diseases and other traits and found that 12% of 45,334 lead associations in the GWAS Catalog are with variants in high linkage disequilibrium with pQTL. We identified 938 genes encoding potential drug targets with variants that influence levels of possible biomarkers. Combining proteomics, genomics and transcriptomics, we provide a valuable resource that can be used to improve understanding of disease pathogenesis and to assist with drug discovery and development.
- 2 December 2021
- Published by Springer Nature in Nature Genetics
- Vol. 53 (12) , 1712-1721
Top Cited PapersLarge-scale integration of the plasma proteome with genetics and disease
The plasma proteome can help bridge the gap between the genome and diseases. Here we describe genome-wide association studies (GWASs) of plasma protein levels measured with 4,907 aptamers in 35,559 Icelanders. We found 18,084 associations between sequence variants and levels of proteins in plasma (protein quantitative trait loci; pQTL), of which 19% were with rare variants (minor allele frequency (MAF) < 1%). We tested plasma protein levels for association with 373 diseases and other traits and identified 257,490 associations. We integrated pQTL and genetic associations with diseases and other traits and found that 12% of 45,334 lead associations in the GWAS Catalog are with variants in high linkage disequilibrium with pQTL. We identified 938 genes encoding potential drug targets with variants that influence levels of possible biomarkers. Combining proteomics, genomics and transcriptomics, we provide a valuable resource that can be used to improve understanding of disease pathogenesis and to assist with drug discovery and development.
- Open Access
- 7 October 2021
- Published by Springer Nature in Communications Biology
- Vol. 4 (1) , 1-9
A genome-wide meta-analysis uncovers six sequence variants conferring risk of vertigo
Vertigo is the leading symptom of vestibular disorders and a major risk factor for falls. In a genome-wide association study of vertigo (Ncases = 48,072, Ncontrols = 894,541), we uncovered an association with six common sequence variants in individuals of European ancestry, including missense variants in ZNF91, OTOG, OTOGL, and TECTA, and a cis-eQTL for ARMC9. The association of variants in ZNF91, OTOGL, and OTOP1 was driven by an association with benign paroxysmal positional vertigo. Using previous reports of sequence variants associating with age-related hearing impairment and motion sickness, we found eight additional variants that associate with vertigo. Although disorders of the auditory and the vestibular system may co-occur, none of the six genome-wide significant vertigo variants were associated with hearing loss and only one was associated with age-related hearing impairment. Our results uncovered sequence variants associating with vertigo in a genome-wide association study and implicated genes with known roles in inner ear development, maintenance, and disease.
- 7 October 2021
- Published by Springer Nature in Communications Biology
- Vol. 4 (1) , 1-9
Open AccessA genome-wide meta-analysis uncovers six sequence variants conferring risk of vertigo
Vertigo is the leading symptom of vestibular disorders and a major risk factor for falls. In a genome-wide association study of vertigo (Ncases = 48,072, Ncontrols = 894,541), we uncovered an association with six common sequence variants in individuals of European ancestry, including missense variants in ZNF91, OTOG, OTOGL, and TECTA, and a cis-eQTL for ARMC9. The association of variants in ZNF91, OTOGL, and OTOP1 was driven by an association with benign paroxysmal positional vertigo. Using previous reports of sequence variants associating with age-related hearing impairment and motion sickness, we found eight additional variants that associate with vertigo. Although disorders of the auditory and the vestibular system may co-occur, none of the six genome-wide significant vertigo variants were associated with hearing loss and only one was associated with age-related hearing impairment. Our results uncovered sequence variants associating with vertigo in a genome-wide association study and implicated genes with known roles in inner ear development, maintenance, and disease.